Used to control agitation in Alzheimer's, the drugs Quetiapine (Seroquel) and rivastigmine (Exelon) have been under the researchers gaze in a carefully controlled study. The findings show they are ineffective and in the case of Quetiapine, cause significant cognitive decline. Read more.